Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-11-000149
Filing Date
2011-08-31
Accepted
2011-08-31 17:19:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 ONCOG13G0811 oncog13g0811.htm SC 13G 68591
  Complete submission text file 0000905718-11-000149.txt   70128
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45969 | Film No.: 111069139
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

EIN.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G